Skip to main content

Biopharma Startups

Updated November 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
915
Total Funding
$1.3B
Avg Funding
$53.1M
Global Reach
5
countries

Top Cities for Biopharma

Baltimore
Morristown
Fort Lee
Houston
San Francisco
Oakland

Recently Funded Companies

Export
Baltimore, United States

Our mission is to develop a superior vaccine platform to improve clinical outcomes for cancer patients

$250K raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Morristown, United States

B1 Health offers a platform for clinical trial design optimization, documentation, process tracking & insight generation for biotech firms.

$350K raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Fort Lee, United States

Nuvectis Pharma is a biopharmaceutical company intended to develop novel targeted therapeutics for the treatment of cancer.

$100.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Houston, United States

FibroBiologics is a regenerative medicine company developing an innovative solution for chronic disease treatment using fibroblast cells.

$3.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

$10.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Oakland, United States

Oblenio Bio is a biotechnology company that develops T-cell engager therapeutic candidates for autoimmune disease treatment.

$62.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Vancouver, United States

Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins

$100.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Austin, United States

Ollin Biosciences develops ophthalmic therapies focused on treating serious vision-threatening diseases.

$330.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

Anodyne Nanotech is a preclinical-stage biotech company that develops differentiated, transdermal forms of high-value drugs.

$12.6M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Carlsbad, United States

Rapalogix Health is a biotechnology company focused on developing longevity-based solutions for skin health and dermatological conditions.

$20.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Houdini Bio develops computational synthetic biology tools to redesign DNA constructs for improved genetic medicines.

$1.9M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Lund, Sweden

Emulsi Biotech is a biotechnology company that develops lipid technology to deliver biologic drugs orally.

$743K raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Altrincham, United Kingdom

FinalDose develops programmable DNA therapeutics that eliminate diseased cells by targeting pathogenic genetic sequences.

Jun 2026

Founder Contacts

41,000+ verified contacts

Los Altos, United States

MultiValent Biotherapies is a biotechnology company.

$27.4M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Álava, Spain

Naturmet develops and operates biomethane production plants in Spain.

$69.3M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

$75.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Austin, United States

Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.

$75.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

SonoThera develops ultrasound-based technologies for delivering genetic therapies to targeted tissues.

$125.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

City Therapeutics is a biopharmaceutical company focused on developing RNA interference (RNAi)-based medicines for a range of diseases.

$99.5M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Wilmington, United States

Liminatus Pharma is a immuno‑oncology company offering CD47‑blockade antibody solutions to prevent anemia and thrombocytopenia.

$1.9M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Vancouver, Canada

ME Therapeutics is a biotechnology company that focuses on discovery & development of myeloid cell targeted immuno oncology drugs.

$361K raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Wilmington, United States

NRx Pharmaceuticals is a pharmaceutical company developing therapeutics for the treatment of central nervous system disorders.

$22.3M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Aliso Viejo, United States

Mammogen specializes in improving the detection, diagnosis, and treatment of breast cancer, from end-to-never-end.

$30.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Watertown, United States

Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function.

$10.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Waltham, United States

Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.

$150.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Showing 76 to 100 of 915 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.

Average Funding
$53.1M
Total Funding Tracked
$1.3B
Countries Represented
5

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Vancouver
2 companies$100.4M
2.Austin
2 companies$405.0M
3.Cambridge
2 companies$174.5M
4.Wilmington
2 companies$24.2M
5.Baltimore
1 companies$250K

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked